Cite
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.
MLA
Anastasilakis, Athanasios D., et al. “Activins, Follistatins and Inhibins in Postmenopausal Osteoporosis: A Proof of Concept, Case-Control Study.” Metabolism: Clinical and Experimental, vol. 141, Apr. 2023, p. 155397. EBSCOhost, https://doi.org/10.1016/j.metabol.2022.155397.
APA
Anastasilakis, A. D., Polyzos, S. A., Rodopaios, N. E., Makras, P., Kumar, A., Kalra, B., & Mantzoros, C. S. (2023). Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism: Clinical and Experimental, 141, 155397. https://doi.org/10.1016/j.metabol.2022.155397
Chicago
Anastasilakis, Athanasios D, Stergios A Polyzos, Nikolaos E Rodopaios, Polyzois Makras, Ajay Kumar, Bhanu Kalra, and Christos S Mantzoros. 2023. “Activins, Follistatins and Inhibins in Postmenopausal Osteoporosis: A Proof of Concept, Case-Control Study.” Metabolism: Clinical and Experimental 141 (April): 155397. doi:10.1016/j.metabol.2022.155397.